Medicine Supply Notification: Disopyramide 100mg and 150mg capsules
Department of Health and Social Care (DHSC) has issued a Medicine Supply Notification (MSN) for Disopyramide 100mg and 150mg capsules.
MSN/2022/030
Tier 2 – medium impact
Date of issue: 23/03/2022
- Supplies of disopyramide 100mg capsules are very limited until the end of March 2022.
- Disopyramide 150mg capsules are out of stock until the end of March 2022.
- Disopyramide 250mg MR tablets remain available and can support an increase in demand.
Community pharmacies should note that where patients have insufficient supplies to last until the resupply date:
- Emergency orders can be placed directly with Drugsrus for supply of a limited volume of disopyramide 100mg capsules to cover until the resupply date (see supporting information). Email nhs@drugsrus.co.uk for further information.
- If this stock is no longer available, pharmacists should refer the patient back to their GP to seek specialist cardiology advice on alternative treatment options.
- For patients requiring disopyramide 150mg capsules pharmacists should refer the patient back to their GP to seek specialist cardiology advice on alternative treatment options (see supporting information).
In all settings patients should be counselled on any new formulation and dose change, and advised to report any adverse effects or recurrence of symptoms.
A copy of this medicine supply notification, including further information, has been sent to all pharmacy NHS email addresses.
DHSC and NHSE/I have now launched an online Medicines Supply Tool, which provides up to date information about medicine supply issues. The contents of these MSNs can now be viewed on the Tool. To access the Tool you will be required to register with the SPS website.
New shortages not listed on the SPS website, can be reported using our shortage reporting tool.
